Current Studies
Clinical Trial List
The studies currently being conducted under the care of Wellness Oncology & Hematology. Select a trial to view full details on the study registry.
Open Trials
Below are our current and recent clinical trials, organized by condition. Listings link to full protocol details.
Breast Cancer
HR+/HER2- Advanced or Metastatic
Open and Enrolling
An Open-Label, Randomized, Multicenter Phase 3 Study Investigating the Efficacy and Safety of BGB-43395 Plus Letrozole Versus CDK4/6 Inhibitors (Abemaciclib, Palbociclib, Ribociclib) Plus Letrozole in Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Systemic Anticancer Treatment for Advanced or Metastatic Disease
HR+/HER2- Advanced or Metastatic (FOURLIGHT-3)
Active, no longer recruiting
An Interventional, Open-Label, Randomized, Multicenter Phase 3 Study of PF-07220060 Plus Letrozole Compared to CDK4/6 Inhibitor Plus Letrozole in Participants Over 18 Years of Age With Hormone Receptor (HR)-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Who Have Not Received Any Prior Systemic Anticancer Treatment for Advanced/Metastatic Disease (FOURLIGHT-3)
Is a Trial Right for You?
Talk with our team.
Our physicians will explain the potential benefits, side effects, and risks of any clinical trial, and answer your questions, so you can decide what is right for you.